Biological properties and functional determinants of the urotensin II receptorPROULX, Christophe D; HOLLERAN, Brian J; LAVIGNE, Pierre et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 5, pp 691-699, issn 0196-9781, 9 p.Article

Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptorHOLLERAN, Brian J; DOMAZET, Ivana; BEAULIEU, Marie-Eve et al.Biochemical pharmacology. 2009, Vol 77, Num 8, pp 1374-1382, issn 0006-2952, 9 p.Article

The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humansCHERIYAN, Joseph; BURTON, Timothy J; BRADLEY, Timothy J et al.British journal of clinical pharmacology. 2009, Vol 68, Num 4, pp 518-523, issn 0306-5251, 6 p.Article

Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in JapaneseSUZUKI, Susumu; ZONG WENYI; OKA, Yoshitomo et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 10, pp 1803-1808, issn 0196-9781, 6 p.Article

Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-IIBOIVIN, Stephane; SEGALAS-MIIAZZO, Isabelle; GUILHAUDIS, Laure et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 5, pp 700-710, issn 0196-9781, 11 p.Article

Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissuesMORIMOTO, Ryo; SATOH, Fumitoshi; MURAKAMI, Osamu et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 5, pp 873-880, issn 0196-9781, 8 p.Article

Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brainMORI, Masaaki; FUJINO, Masahiko.Peptides (New York, NY. 1980). 2004, Vol 25, Num 10, pp 1815-1818, issn 0196-9781, 4 p.Article

Complex effects of Gillichthys urotensin II on rat aortic stripsGIBSON, A.British journal of pharmacology. 1987, Vol 91, Num 1, pp 205-212, issn 0007-1188Article

Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitusSIDHARTA, Patricia N; RAVE, Klaus; HEINEMANN, Lutz et al.British journal of clinical pharmacology. 2009, Vol 68, Num 4, pp 502-510, issn 0306-5251, 9 p.Article

Elevated expression of urotensin II and its receptor in great artery of type 2 diabetes and its significanceNING XIE; LUQI LIU.Biomedicine & pharmacotherapy. 2009, Vol 63, Num 10, pp 734-741, issn 0753-3322, 8 p.Article

Effects of dogfish urotensin II on lipid mobilization in the fasted dogfish, Scyliorhinus caniculaCONLON, J. M; AGIUS, L; GEORGE, K et al.General and comparative endocrinology. 1994, Vol 93, Num 2, pp 177-180, issn 0016-6480Article

Neurohormones from fish tails: the caudal neurosecretory system. I: Urophysiology and the caudal neurosecretory system of fishesBERN, H. A; PEARSON, D; LARSON, B. A et al.Recent progress in hormone research. 1985, Vol 41, pp 533-552, issn 0079-9963Article

Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: Comparison with endothelin-1HIROSE, Takuo; TAKAHASHI, Kazuhiro; MORI, Nobuyoshi et al.Peptides (New York, NY. 1980). 2009, Vol 30, Num 6, pp 1124-1129, issn 0196-9781, 6 p.Article

The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptorsHEROLD, Christopher L; BEHM, David J; BUCKLEY, Peter T et al.British journal of pharmacology. 2003, Vol 139, Num 2, pp 203-207, issn 0007-1188, 5 p.Article

Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophyKOMPA, Andrew R; WANG, Bing H; PHROMMINTIKUL, Arintaya et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 8, pp 1523-1530, issn 0196-9781, 8 p.Article

A quantitative study to assess synergistic interactions between urotensin II and angiotensin IILAMARRE, Neil S; TALLARIDA, Ronald J.European journal of pharmacology. 2008, Vol 586, Num 1-3, pp 350-351, issn 0014-2999, 2 p.Article

Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heartDOAN, N. D; NGUYEN, Ttm; LETOURNEAU, M et al.British journal of pharmacology. 2012, Vol 166, Num 1, pp 243-257, issn 0007-1188, 15 p.Article

Identification of new agonists of urotensin-II from a cyclic peptide libraryODAGAMI, Takenao; TSUDA, Yuko; KOGAMI, Yuji et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 18, pp 6742-6747, issn 0968-0896, 6 p.Article

Urotensin II is raised in children with congenital heart diseaseSIMPSON, C. M; PENNY, D. J; STOCKER, C. F et al.Heart (London 1996). 2006, Vol 92, Num 7, pp 983-984, issn 1355-6037, 2 p.Article

Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factorYOSHIMOTO, Takanobu; MATSUSHITA, Mika; HIRATA, Yukio et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 10, pp 1775-1781, issn 0196-9781, 7 p.Article

Urotensin II-immunoreactive neurons in the caudal neurosecretory system of freshwater and seawater fishOWADA, K; KAWATA, M; AKAJI, K et al.Cell and tissue research. 1985, Vol 239, Num 2, pp 349-354, issn 0302-766XArticle

Does cigarette smoking increase plasma urotensin II concentrations?GOLD, S. J; THOMPSON, J. P; WILLIAMS, J. P et al.European journal of clinical pharmacology. 2007, Vol 63, Num 3, pp 253-257, issn 0031-6970, 5 p.Article

Urotensin-II immunoreactivity in children with chronic glomerulonephritisBALAT, Ayse; KARAKÖK, Metin; YILMAZ, Kutluhan et al.Renal failure. 2007, Vol 29, Num 5, pp 573-578, issn 0886-022X, 6 p.Article

The role of urotensin II in cardiovascular and renal physiology and diseasesZHU, Yi-Chun; ZHU, Yi-Zhun; MOORE, Philip Keith et al.British journal of pharmacology. 2006, Vol 148, Num 7, pp 884-901, issn 0007-1188, 18 p.Article

Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathyLAPP, Harald; BOERRIGTER, Guido; COSTELLO-BOENIGTER, Lisa C et al.International journal of cardiology. 2004, Vol 94, Num 1, pp 93-97, issn 0167-5273, 5 p.Article